A surgical stapler is a medical device, which is commonly used during a surgical procedure. These devices are versatile and highly efficient and have advanced safety parameters to overcome postoperative complications that often occur due to staple line leaks.
The Asia Pacific surgical stapling market size was valued to be around $XX million in 2018 and is expected to grow at a CAGR of around 7.76% over the forecast period of 2019-2027. The market is expected to exhibit lucrative growth opportunities in the coming years owing to the increasing preference for staples over sutures.
The incidence of chronic illnesses such as cardiovascular, orthopedic, and neurological diseases is increasing day by day across the world. Orthopedic diseases such as arthritis and spinal deformity and neurological disorders like dementia and epilepsy have also been on a rising trend globally over the past few years. Many of these diseases require surgical intervention. So consequently, the rise in a number of surgical procedures will increase the demand for surgical stapling devices in the developing markets of the APAC.
The Asia Pacific market analysis considers the contribution by countries such as China, India, Japan, Australia, South Korea and the remaining countries collectively forming the Rest of Asia Pacific regional segment towards the market growth.
Smith and Nephew PLC, Atricure Inc., Abbott Vascular Inc., Grena, Boston Scientific Corporation, Johnson & Johnson, Ethicon Inc., St. Jude Medical Inc. (Acquired By Abbott Laboratories), Stryker Corporation, Dextera Surgical, Cook Medical LLC, Intuitive Surgical, Medtronic PLC, ConMed Corporation, and 3M Company are the major companies that are extensively profiled in our report.